- Home
- PROK vs KNDI Comparison
PROK vs KNDI Comparison
Compare PROK & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- KNDI
- Stock Information
- Founded
- PROK 2015
- KNDI 2002
- Country
- PROK United States
- KNDI China
- Employees
- PROK N/A
- KNDI 840
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- KNDI Auto Manufacturing
- Sector
- PROK Health Care
- KNDI Consumer Discretionary
- Exchange
- PROK Nasdaq
- KNDI Nasdaq
- Market Cap
- PROK 126.8M
- KNDI 112.8M
- IPO Year
- PROK N/A
- KNDI N/A
- Fundamental
- Price
- PROK $0.60
- KNDI $1.33
- Analyst Decision
- PROK Buy
- KNDI
- Analyst Count
- PROK 4
- KNDI 0
- Target Price
- PROK $5.00
- KNDI N/A
- AVG Volume (30 Days)
- PROK 410.9K
- KNDI 147.8K
- Earning Date
- PROK 05-09-2025
- KNDI 05-15-2025
- Dividend Yield
- PROK N/A
- KNDI N/A
- EPS Growth
- PROK N/A
- KNDI N/A
- EPS
- PROK N/A
- KNDI N/A
- Revenue
- PROK $76,000.00
- KNDI $118,127,232.00
- Revenue This Year
- PROK N/A
- KNDI N/A
- Revenue Next Year
- PROK N/A
- KNDI N/A
- P/E Ratio
- PROK N/A
- KNDI N/A
- Revenue Growth
- PROK N/A
- KNDI N/A
- 52 Week Low
- PROK $0.68
- KNDI $0.89
- 52 Week High
- PROK $4.44
- KNDI $2.98
- Technical
- Relative Strength Index (RSI)
- PROK 21.04
- KNDI 43.61
- Support Level
- PROK $0.87
- KNDI $1.30
- Resistance Level
- PROK $1.00
- KNDI $1.47
- Average True Range (ATR)
- PROK 0.10
- KNDI 0.07
- MACD
- PROK -0.01
- KNDI -0.02
- Stochastic Oscillator
- PROK 3.98
- KNDI 11.11
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.